NASDAQ:ALLR

Allarity Therapeutics Stock Predictions

etoro logo Buy ALLR
*Your capital is at risk
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLR Prediction Chart

ALLR Predictions History

Latest community submissions for ALLR.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 28, 2025 $1.52 -4.23% $1.50 V 98.49% 1
Aug 28, 2025 $1.55 -2.64% $1.50 V 96.80% 1
Aug 28, 2025 Bullish $1.50 X 0
Jul 10, 2025 $1.03 -1.54% $1.08 X 95.73% 0
Jul 10, 2025 $50.00 +4 754.37% Unrealistic Excluded from avg $1.08 V 0.00% 1
Jul 9, 2025 $1.01 -1.61% $1.05 X 96.51% 0
Jul 9, 2025 Bullish $1.05 V 1
May 12, 2025 Bullish $1.02 X 0
Apr 25, 2025 $1.02 -4.45% $1.13 X 90.47% 0
Apr 25, 2025 $1.04 -2.78% $1.13 X 92.05% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLARITY THERAPEUTICS, INC.
Allarity Therapeutics
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE